Blackrock Health Sciences Etf Price To Sales
| BME Etf | USD 39.38 0.34 0.87% |
BlackRock Health Sciences fundamentals help investors to digest information that contributes to BlackRock Health's financial success or failures. It also enables traders to predict the movement of BlackRock Etf. The fundamental analysis module provides a way to measure BlackRock Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BlackRock Health etf.
BlackRock |
BlackRock Health Sciences ETF Price To Sales Analysis
BlackRock Health's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current BlackRock Health Price To Sales | 66.42 X |
Most of BlackRock Health's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BlackRock Health Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, BlackRock Health Sciences has a Price To Sales of 66 times. This is much higher than that of the Capital Markets family and significantly higher than that of the Financials category. The price to sales for all United States etfs is notably lower than that of the firm.
BlackRock Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BlackRock Health's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of BlackRock Health could also be used in its relative valuation, which is a method of valuing BlackRock Health by comparing valuation metrics of similar companies.BlackRock Health is currently under evaluation in price to sales as compared to similar ETFs.
BlackRock Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, BlackRock Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to BlackRock Health's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
BlackRock Fundamentals
| Return On Equity | 0.0901 | ||||
| Return On Asset | 0.0017 | ||||
| Profit Margin | 6.84 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 545.4 M | ||||
| Shares Outstanding | 13.6 M | ||||
| Shares Owned By Institutions | 23.04 % | ||||
| Number Of Shares Shorted | 8.01 K | ||||
| Price To Earning | 6.69 X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 66.42 X | ||||
| Revenue | 8.19 M | ||||
| Gross Profit | 7.73 M | ||||
| EBITDA | 20.02 M | ||||
| Net Income | 20.02 M | ||||
| Cash And Equivalents | 16.68 K | ||||
| Total Debt | 60.69 K | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 0.36 X | ||||
| Book Value Per Share | 44.20 X | ||||
| Cash Flow From Operations | 4.76 M | ||||
| Short Ratio | 0.26 X | ||||
| Earnings Per Share | 3.93 X | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 530.76 M | ||||
| Total Asset | 596.1 M | ||||
| Retained Earnings | 170.52 M | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 5.86 % | ||||
| Net Asset | 596.1 M | ||||
| Last Dividend Paid | 2.56 |
About BlackRock Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BlackRock Health Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BlackRock Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BlackRock Health Sciences based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in BlackRock Etf
BlackRock Health financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Health security.